Registered entities
GLYCOS BIOTECHNOLOGIES INC
Reg. No. 208797775United States
Innovation
6 patent families (2 granted) — focus: Human necessities, Chemistry & metallurgy; filing pace accelerating. Cited 75 times.
| Year | Filings |
|---|---|
| 2020 | 1 |
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 2 |
| 2024 | 3 |
| 2025 | 3 |
| 2026 | 1 |
Investor mix
6 investors on record; lead investors include DFJ, Mercury Fund, EIV Capital.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 5 | 83% |
| Private equity | 1 | 17% |
